The Latest Breaking News from ICU Medical

Upgrades

ICU Medical (NASDAQ:ICUI) brought in sales totaling $543.12 million during Q1 according to data provided by Benzinga Pro. However, earnings decreased 291.06%, resulting in a loss of $38.07 million.

ICU Medical Inc (NASDAQ:ICUI) reported Q1 sales of $543.1 million vs. Raymond James' estimate of $530 million.  Core ICU beat by $7 million, while newly acquired Smiths Medical missed by $5 million.  With an Outperform rating, the analysts lowered the price target from $265 to $235. Adjusted EPS was $1.82, down from Raymond James' estimate…

Surging chronic diseases worldwide and an aging population should fuel the medical device industry’s growth. Therefore, it could be wise to bet on quality medical device stocks ICU Medical (ICUI) and Natus Medical (NTUS), which are currently trading at discounts to their peers. These stocks are rated Strong Buy in…